Avalo Therapeutics Investor Relations Material
Latest events
Corporate Presentation
19 Jun, 2025
Q1 2025
12 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Avalo Therapeutics Inc
Access all reports
Avalo Therapeutics Inc. is a U.S.-based biotechnology company focused on the development of targeted therapies for immune-mediated diseases. The company specializes in discovering and advancing treatments for autoimmune and rare diseases by leveraging its expertise in immunology and precision medicine. Avalo Therapeutics Inc. conducts research across various stages of drug development, from early discovery to clinical trials. The company is headquartered in Rockville, Maryland, and its shares are listed on the NASDAQ.
Key slides for Avalo Therapeutics Inc
Corporate Presentation
Avalo Therapeutics Inc
Corporate Presentation
Avalo Therapeutics Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
AVTX
Country
🇺🇸 United States